EMA to review MAA for avalglucosidase alfa, enzyme replacement therapy to treat Pompe disease
The MHRA in the UK has granted Promising Innovative Medicine designation for avalglucosidase and US FDA has granted it…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.